Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aliada Therapeutics

Request full access

Developing drugs for the treatment of diseases of the central nervous system (cns)

Boston, United StatesFounded 2021Biotech & Life Sciences

About Aliada Therapeutics

Aliada Therapeutics is a biotechnology company focused on developing innovative therapeutics that advance the delivery of large molecules across the blood-brain barrier. The company's lead program, ALIA 1758, is a differentiated bispecific antibody targeting pyroglutamate amyloid beta and TfR, aimed at effectively clearing amyloid beta plaques from the brain. This approach offers improved convenience and efficacy compared to current treatments. Aliada Therapeutics serves clients in the pharmaceutical and healthcare sectors, particularly those involved in neurology and neurodegenerative diseases. Operating in the biotechnology market, the company employs a business model centered on research and development, clinical trials, and eventual commercialization of its therapeutic solutions. Revenue is generated through partnerships, licensing agreements, and potentially direct sales of approved therapies.

Source: Dealroom company data

Aliada Therapeutics in the Boston ecosystem

Live from Dealroom

The Aliada Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$229k

2 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Aliada Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.